ArticleGene therapy2024

CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s disease.

Luis Fernando Narváez-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.